NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

Great post ATL. Here is a titbit from an article published today that mentions upcoming DCVAX.

From Article:

6.2.2. Vaccine-Based Therapy
Training the immune system with vaccination is a very hot topic nowadays, and it can be a useful tool against tumors as well. Tumor-associated and tumor-specific antigenes (TAA and TSA) generate the immune response: a protein vaccine against EGFRvIII (rindopepimut) has promising early results [41]. Another potential target is survivin from the apoptosis inhibitor protein family (SurVaxM) [42]. Besides protein-based vaccines, preliminary results with activated autologous dendritic cells (e.g., DCVax) are also hopeful.
HSPPC-96 (heat shock protein peptide comlex-96) is the pioneer representative of personalized cancer vaccines. It is made by training the patient’s immune system to recognize the gp96 heat shock protein and its related proteins that are extracted from his or her own tumor tissue [43].

Page 9 of the article.

[url][/url][tag]https://www.mdpi.com/1422-0067/22/18/10005[/tag]